Probe and a method for use with a probe

• US 8,126,525 B2
• Filed: 12/01/2006
• Issued: 02/28/2012
• Est. Priority Date: 12/02/2005
• Status: Active Grant

• Current Assignee: GE Healthcare Finland OY (General Electric Company)
• Original Assignee: GE Healthcare Finland OY (General Electric Company)
• Inventors: Rantala, Borje
• Primary Examiner(s): Winakur, Eric
• Assistant Examiner(s): Liu, Chu Chuan (JJ)
• Application Number:
  US11/565,905
• Publication Number:
  US 20070129616A1
• Time in Patent Office: 1,915 Days
• Field of Search: 600/310, 600/323, 600/331, 600/340
• US Class Current: 600/323
• CPC Class Codes: A61B 5/14551 for measuring blood gases

Abstract

The invention relates to a probe and a method for use with a probe, which produces signals indicative of the light absorption of arterial blood at least at a first light wave-length and at a second light wavelength. In order to indicate if the probe is not properly attached to a tissue site the method comprises measuring with at a third wave-length. The third wavelength is chosen so that human tissue is less transparent than at the first and second wavelengths.

Claims

1. A method comprising:

determining if a probe capable of producing signals indicative of light absorption of arterial blood at a first light wavelength and at a second light wavelength is not properly attached to a tissue site by measuring with a third light wavelength, which does not penetrate the tissue site as much as the first and second wavelengths; and

comparing a current transfer ratio (CTR) of at least one of the first and second light wavelengths with a CTR of the third light wavelength.

2. The method of claim 1, wherein the third light wavelength is shorter than 600 nm or longer than 1000 nm.

3. The method of claim 2, wherein the third light wavelength is about 550-500 nm or 1300 nm or more.

4. The method of claim 1, wherein the probe is a pulse oximeter probe.

5. A probe comprising:

a light source to send optical signals through tissue at least at a first light wavelength and at a second light wavelength;

a detector to receive optical signals after transmission of the first and second light wavelengths through the tissue and to produce signals based on the first and second light wavelengths respectively that are indicative of light absorption of arterial blood;

a light emitter to produce a signal at a third light wavelength to determine if the probe is not properly attached to a tissue site, wherein the third light wavelength does not penetrate the tissue site as much as the first and second light wavelengths; and

a unit for comparing a current transfer ratio (CTR) of at least one of the first and second light wavelengths with a CTR of the third light wavelength.

6. The probe of claim 5, wherein the third wavelength is shorter than 600 nm or longer than 1000 nm.

7. The probe of claim 6, wherein the third wavelength is essentially 500-550 nm or 1300 nm or more.

8. The probe of claim 5, wherein the probe is a pulse oximeter probe.